Azar Alex M II
SEC Form 4 insider trading activity
Azar Alex M II has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 15, 2026.
On the most recent filing, Azar Alex M II is listed as Director at Guardant Health, Inc. Inside the rolling window, Azar Alex M II reported no open-market purchases and 2 open-market sales totaling $156K in GH. The largest disclosed transaction in the window is a sale of 826 GH shares on Sep 16, 2026, worth $145K.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$156K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Azar Alex M II made?
Azar Alex M II has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Azar Alex M II trade?
Azar Alex M II has filed SEC Form 4 disclosures for 1 company, including GH.
When was Azar Alex M II's most recent SEC Form 4 filing?
Azar Alex M II's most recent SEC Form 4 filing on Tracefour is dated Oct 15, 2026.
What is Azar Alex M II's total buy and sell value in the current window?
Inside the rolling retention window, Azar Alex M II bought $0 and sold $156K based on SEC Form 4 filings.
What was Azar Alex M II's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 826 GH shares on 2026-09-16, worth $145K, per SEC Form 4 filings.